Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02793219
Title Provenge Followed by Docetaxel in Castration-Resistant Prostate Cancer
Recruitment Withdrawn
Gender male
Phase Phase II
Variant Requirements No
Sponsors The University of Texas Health Science Center, Houston
Indications

prostate adenocarcinoma

Therapies

Docetaxel + Sipuleucel-T

Age Groups: adult
Covered Countries USA


No variant requirements are available.